253 related articles for article (PubMed ID: 36142738)
21. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
Malik P; Arumugam PI; Yee JK; Puthenveetil G
Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
[TBL] [Abstract][Full Text] [Related]
22. 2021 update on clinical trials in β-thalassemia.
Musallam KM; Bou-Fakhredin R; Cappellini MD; Taher AT
Am J Hematol; 2021 Nov; 96(11):1518-1531. PubMed ID: 34347889
[TBL] [Abstract][Full Text] [Related]
23. A synthetic model of human beta-thalassemia erythropoiesis using CD34+ cells from healthy adult donors.
Lee YT; Kim KS; Byrnes C; de Vasconcellos JF; Noh SJ; Rabel A; Meier ER; Miller JL
PLoS One; 2013; 8(7):e68307. PubMed ID: 23861885
[TBL] [Abstract][Full Text] [Related]
24. Elevated CDKN1A (P21) mediates β-thalassemia erythroid apoptosis, but its loss does not improve β-thalassemic erythropoiesis.
Liang R; Lin M; Menon V; Qiu J; Menon A; Breda L; Arif T; Rivella S; Ghaffari S
Blood Adv; 2023 Nov; 7(22):6873-6885. PubMed ID: 37672319
[TBL] [Abstract][Full Text] [Related]
25. Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.
Mettananda S; Fisher CA; Hay D; Badat M; Quek L; Clark K; Hublitz P; Downes D; Kerry J; Gosden M; Telenius J; Sloane-Stanley JA; Faustino P; Coelho A; Doondeea J; Usukhbayar B; Sopp P; Sharpe JA; Hughes JR; Vyas P; Gibbons RJ; Higgs DR
Nat Commun; 2017 Sep; 8(1):424. PubMed ID: 28871148
[TBL] [Abstract][Full Text] [Related]
26. Heme-regulated eIF2α kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis.
Suragani RN; Zachariah RS; Velazquez JG; Liu S; Sun CW; Townes TM; Chen JJ
Blood; 2012 May; 119(22):5276-84. PubMed ID: 22498744
[TBL] [Abstract][Full Text] [Related]
27. Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells.
Pavani G; Fabiano A; Laurent M; Amor F; Cantelli E; Chalumeau A; Maule G; Tachtsidi A; Concordet JP; Cereseto A; Mavilio F; Ferrari G; Miccio A; Amendola M
Blood Adv; 2021 Mar; 5(5):1137-1153. PubMed ID: 33635334
[TBL] [Abstract][Full Text] [Related]
28. Accelerated telomere shortening in β-thalassemia/HbE patients.
Chaichompoo P; Pattanapanyasat K; Winichagoon P; Fucharoen S; Svasti S
Blood Cells Mol Dis; 2015 Aug; 55(2):173-9. PubMed ID: 25631622
[TBL] [Abstract][Full Text] [Related]
29. Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleation.
Feola M; Zamperone A; Moskop D; Chen H; Casu C; Lama D; Di Martino J; Djedaini M; Papa L; Martinez MR; Choesang T; Bravo-Cordero JJ; MacKay M; Zumbo P; Brinkman N; Abrams CS; Rivella S; Hattangadi S; Mason CE; Hoffman R; Ji P; Follenzi A; Ginzburg YZ
Commun Biol; 2021 May; 4(1):517. PubMed ID: 33941818
[TBL] [Abstract][Full Text] [Related]
30. The Interplay Between Peroxiredoxin-2 and Nuclear Factor-Erythroid 2 Is Important in Limiting Oxidative Mediated Dysfunction in β-Thalassemic Erythropoiesis.
Matte A; De Falco L; Iolascon A; Mohandas N; An X; Siciliano A; Leboeuf C; Janin A; Bruno M; Choi SY; Kim DW; De Franceschi L
Antioxid Redox Signal; 2015 Dec; 23(16):1284-97. PubMed ID: 26058667
[TBL] [Abstract][Full Text] [Related]
31. Iron metabolism and ineffective erythropoiesis in beta-thalassemia mouse models.
Ramos P; Melchiori L; Gardenghi S; Van-Roijen N; Grady RW; Ginzburg Y; Rivella S
Ann N Y Acad Sci; 2010 Aug; 1202():24-30. PubMed ID: 20712768
[TBL] [Abstract][Full Text] [Related]
32. alpha-Thalassemia-like globin gene expression by primitive erythrocytes derived from human embryonic stem cells.
Honig GR; Lu SJ; Feng Q; Vida LN; Lee BS; Lanza R
Hemoglobin; 2010 Jan; 34(2):145-50. PubMed ID: 20353349
[TBL] [Abstract][Full Text] [Related]
33. Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.
Gardenghi S; Grady RW; Rivella S
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1089-107. PubMed ID: 21075282
[TBL] [Abstract][Full Text] [Related]
34. Erythroblastic inclusions in dominantly inherited beta thalassemias.
Ho PJ; Wickramasinghe SN; Rees DC; Lee MJ; Eden A; Thein SL
Blood; 1997 Jan; 89(1):322-8. PubMed ID: 8978308
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of microRNA 101-3p during erythropoiesis in β-thalassemia/HbE.
Phannasil P; Sukhuma C; Nauphar D; Nuamsee K; Svasti S
Blood Cells Mol Dis; 2023 Nov; 103():102781. PubMed ID: 37478523
[TBL] [Abstract][Full Text] [Related]
36. Introduction to the Thalassemia Syndromes: Molecular Medicine's Index Case.
Benz EJ
Hematol Oncol Clin North Am; 2023 Apr; 37(2):245-259. PubMed ID: 36907601
[TBL] [Abstract][Full Text] [Related]
37. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia.
Pootrakul P; Sirankapracha P; Hemsorach S; Moungsub W; Kumbunlue R; Piangitjagum A; Wasi P; Ma L; Schrier SL
Blood; 2000 Oct; 96(7):2606-12. PubMed ID: 11001918
[TBL] [Abstract][Full Text] [Related]
38. Activin Receptor-Ligand Trap for the Treatment of β-thalassemia: A Serendipitous Discovery.
Brancaleoni V; Nava I; Delbini P; Duca L; Motta I
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020075. PubMed ID: 33194149
[TBL] [Abstract][Full Text] [Related]
39. Ineffective erythropoiesis in beta-thalassemia major is due to apoptosis at the polychromatophilic normoblast stage.
Mathias LA; Fisher TC; Zeng L; Meiselman HJ; Weinberg KI; Hiti AL; Malik P
Exp Hematol; 2000 Dec; 28(12):1343-53. PubMed ID: 11146156
[TBL] [Abstract][Full Text] [Related]
40. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.
Ginzburg Y; Rivella S
Blood; 2011 Oct; 118(16):4321-30. PubMed ID: 21768301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
